Log in
Sign up
Show me
Select...
where
Sinopharm CapitalSinopharm Capital
or
Name
Funding Type
Funded Company
Funding Round Amount (USD)
Investment
Funding Round Date
Funding Round Investor
‌
Ansun BioPharma funding round, May 2018
Series A round
Series A round
Ansun BioPharma
Ansun BioPharma
85,000,000
Investor
LYFE Capital
LYFE Capital
Investor
Matrix Partners China
Matrix Partners China
Investor
Oceanpine Capital
Oceanpine Capital
Investor
VI Ventures
VI Ventures
Investor
‌
Joincap Investment
Investor
Yuanming Capital
Yuanming Capital
Investor
3E Bioventures Capital (3E)
3E Bioventures Capital (3E)
Investor
Sinopharm Capital
Sinopharm Capital
Investor
Lilly Asia Ventures
Lilly Asia Ventures
May 2018
Add data
Get data
‌
Virtualsion Series B round, December 2017
Series B round
Series B round
Virtualsion
Virtualsion
18,000,000
Investor
Bluestem Capital
Bluestem Capital
Investor
PrairieGold Venture Partners
PrairieGold Venture Partners
Investor
Sinopharm Capital
Sinopharm Capital
December 2017
Add data
Get data
‌
Kira Pharmaceuticals Series A round November 2020
Series A round
Series A round
Kira Pharmaceuticals
Kira Pharmaceuticals
46,000,000
Investor
Sinopharm Capital
Sinopharm Capital
Investor
QiMing Venture Partners
QiMing Venture Partners
Investor
Quan Capital
Quan Capital
Investor
6 Dimensions Capital
6 Dimensions Capital
November 2020
Add data
Get data
‌
Dingdang Kuaiyao Series B round October 2020
Series B round
Series B round
Dingdang Kuaiyao
Dingdang Kuaiyao
150,000,000
Investor
Softbank China Venture Capital
Softbank China Venture Capital
Investor
CMB International Capital Corporation
CMB International Capital Corporation
Investor
Sinopharm Capital
Sinopharm Capital
October 2020
Add data
Get data
‌
Virtual Incision Corporation funding round, December 2017
Series B round
Series B round
‌
Virtual Incision
18,000,000
Investor
Bluestem Capital
Bluestem Capital
Investor
PrairieGold Venture Partners
PrairieGold Venture Partners
Investor
Sinopharm Capital
Sinopharm Capital
December 2017
Add data
Get data
‌
Virtual Incision Series B round, December 2017
Series B round
Series B round
‌
Virtual Incision
18,000,000
Investor
Sinopharm Capital
Sinopharm Capital
December 13, 2017
Add data
Get data
‌
Wuhan More Biotechnology Co., Ltd. Series B round, March 2019
Series B round
Series B round
Wuhan More Biotechnology Co., Ltd.
Wuhan More Biotechnology Co., Ltd.
Add data
Get data
Investor
Sinopharm Capital
Sinopharm Capital
March 2019
Add data
Get data
Results per page:
7 results
0 selected